Literature DB >> 12695743

Pathophysiology of disseminated intravascular coagulation (DIC) progresses at a different rate in tissue factor-induced and lipopolysaccharide-induced DIC models in rats.

Hidesaku Asakura1, Yukio Suga, Tomotaka Yoshida, Yasuo Ontachi, Tomoe Mizutani, Minori Kato, Takako Ito, Eriko Morishita, Masahide Yamazaki, Ken-Ichi Miyamoto, Shinji Nakao.   

Abstract

Tissue factor (TF) and lipopolysaccharide (LPS) are frequently used to induce disseminated intravascular coagulation (DIC) in experimental animal models. Although the pathophysiology of DIC may differ depending on which agent is used for induction, previous studies on models of DIC have not distinguished which DIC-inducing agent was used. In the present paper, we evaluate the characteristics of TF-induced and LPS-induced DIC using two types of DIC models, with special reference to selected hemostatic parameters and pathological findings within the kidney. Male Wistar rats were administered TF (3.75 U/kg; sustained infusion for 4 h) or LPS (30 mg/kg; sustained infusion for 4 h) via the tail vein, and blood sampling was performed at 0, 1, 3, 4, 5, 7, 9, 11, and 28 h. Judging from changes in the levels of thrombin-antithrombin complex, fibrinogen levels, and platelet counts, it is reasonable to conclude that the severity of both types of experimental DIC is similar with regard to hemostatic activation and consumption coagulopathy. A marked elevation in the level of D-dimer was noted without any organ dysfunction or much fibrin deposition in the kidney upon administration of TF. However, a markedly prolonged period of elevation in plasminogen activator inhibitor activity, a prolonged depression in antithrombin III activity, severe organ failure, and a markedly prolonged period of fibrin deposition in the kidney was observed following LPS administration. A modest number of the rats from the TF-induced DIC model died during the experimental period, whereas a large number of rats died during LPS-induced DIC, especially after 9 h. Since the time course of the pathophysiology differed remarkably among the TF-induced and LPS-induced DIC models in rats, we recommend that TF-induced and LPS-induced DIC be approached as distinct models in order to determine the implications of their experimental and clinical use.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12695743     DOI: 10.1097/01.mbc.0000061290.28953.57

Source DB:  PubMed          Journal:  Blood Coagul Fibrinolysis        ISSN: 0957-5235            Impact factor:   1.276


  12 in total

1.  Fibrin-modulating nanogels for treatment of disseminated intravascular coagulation.

Authors:  Emily P Mihalko; Megan Sandry; Nicholas Mininni; Kimberly Nellenbach; Halston Deal; Michael Daniele; Kamrouz Ghadimi; Jerrold H Levy; Ashley C Brown
Journal:  Blood Adv       Date:  2021-02-09

2.  Detailed exploration of pathophysiology involving inflammatory status and bleeding symptoms between lipopolysaccharide- and tissue factor-induced disseminated intravascular coagulation in rats.

Authors:  Yukio Suga; Anna Kubo; Hideyuki Katsura; Yukiko Staub; Kiyomichi Tashiro; Shinya Yamada; Eriko Morishita; Hidesaku Asakura
Journal:  Int J Hematol       Date:  2021-04-27       Impact factor: 2.490

3.  Fibrin-specific poly(N-isopropylacrylamide) nanogels for targeted delivery of tissue-type plasminogen activator to treat thrombotic complications are well tolerated in vivo.

Authors:  Emily P Mihalko; Kimberly Nellenbach; Manasi Krishnakumar; Nina Moiseiwitsch; Jennifer Sollinger; Brian C Cooley; Ashley C Brown
Journal:  Bioeng Transl Med       Date:  2021-12-11

4.  Beneficial effect of low-molecular-weight heparin against lipopolysaccharide-induced disseminated intravascular coagulation in rats is abolished by coadministration of tranexamic acid.

Authors:  Hidesaku Asakura; Yoko Sano; Tomotaka Yoshida; Mika Omote; Yasuo Ontachi; Tomoe Mizutani; Masahide Yamazaki; Eriko Morishita; Akiyoshi Takami; Ken-ichi Miyamoto; Shinji Nakao
Journal:  Intensive Care Med       Date:  2004-06-15       Impact factor: 17.440

5.  Significance of decreased plasma D-dimer levels following lipopolysaccharide-induced disseminated intravascular coagulation in rats.

Authors:  Hidesaku Asakura; Yoko Sano; Mika Omote; Tomotaka Yoshida; Yasuo Ontachi; Tomoe Mizutani; Minori Kaneda; Masahide Yamazaki; Eriko Morishita; Akiyoshi Takami; Ken-ichi Miyamoto; Shinji Nakao
Journal:  Int J Hematol       Date:  2004-05       Impact factor: 2.490

Review 6.  Classifying types of disseminated intravascular coagulation: clinical and animal models.

Authors:  Hidesaku Asakura
Journal:  J Intensive Care       Date:  2014-03-06

Review 7.  Proposal for new diagnostic criteria for DIC from the Japanese Society on Thrombosis and Hemostasis.

Authors:  Hidesaku Asakura; Hoyu Takahashi; Toshimasa Uchiyama; Yutaka Eguchi; Kohji Okamoto; Kazuo Kawasugi; Seiji Madoiwa; Hideo Wada
Journal:  Thromb J       Date:  2016-09-28

8.  Non-Lethal Endotoxin Injection: A Rat Model of Hypercoagulability.

Authors:  Marjory B Brooks; James R Turk; Abraham Guerrero; Padma K Narayanan; John P Nolan; Elizabeth G Besteman; Dennis W Wilson; Roberta A Thomas; Cindy E Fishman; Karol L Thompson; Heidrun Ellinger-Ziegelbauer; Jennifer B Pierson; April Paulman; Alan Y Chiang; Albert E Schultze
Journal:  PLoS One       Date:  2017-01-12       Impact factor: 3.240

Review 9.  COVID-19: imbalance of multiple systems during infection and importance of therapeutic choice and dosing of cardiac and anti-coagulant therapies.

Authors:  Habib Haybar; Mahmood Maniati; Najmaldin Saki; Zeinab Deris Zayeri
Journal:  Mol Biol Rep       Date:  2021-04-10       Impact factor: 2.316

10.  BMSCs pre-treatment ameliorates inflammation-related tissue destruction in LPS-induced rat DIC model.

Authors:  Biao Wang; Shuming Wu; Zengshan Ma; Tao Wang; Changyong Yang
Journal:  Cell Death Dis       Date:  2018-10-03       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.